Innospec INC

Innospec Inc. announced robust second quarter 2026 financial results, with total revenues increasing 12% year-over-year to $491.4 million, driven by strong contributions from all business segments.

Innospec Inc. has expanded its Board of Directors to eight members with the appointment of Shelley Bausch, effective July 1, 2026.

Innospec Inc. announced the results of its 2026 Annual Meeting of Stockholders, with all Class I directors re-elected and advisory approval of executive compensation.

Innospec Inc. announced its first quarter 2026 financial results, reporting total revenues of $453.2 million and a 10 percent increase in its semi-annual dividend.

Innospec Inc. reported mixed third-quarter 2025 financial results with strong Fuel Specialties performance offsetting declines in other segments, alongside a 10% dividend increase.

Innospec Inc. reported a decline in second-quarter net income and adjusted EBITDA despite a slight revenue increase, driven by strong Fuel Specialties performance offsetting weaker results in Performance Chemicals and Oilfield Services.

Innospec Inc. announced a 12% increase in net sales for the second quarter of 2026, driven by strong performance across its Fuel Specialties and Oilfield Services segments, alongside a notable improvement in overall operating income.

Innospec reports Q1 2026 net income of $30.4 million on $453.2 million in revenue, reflecting mixed segment performance and increased operating costs.

Innospec Inc. reports a significant decline in Q3 2025 net income and operating cash flow, primarily due to substantial asset impairments and underperformance in its Oilfield Services and Performance Chemicals segments.

Innospec Inc. reported a significant decline in net income and earnings per share for the second quarter and first half of 2025, despite a slight increase in Q2 net sales, primarily due to weaker performance in Oilfield Services and Performance Chemicals.

Innospec Inc. reports a decrease in net sales for Q1 2025, primarily driven by a significant downturn in its Oilfield Services segment, despite growth in Performance Chemicals.

Innospec Inc. saw a mixed third quarter with strong performance in its Performance Chemicals segment offsetting a significant decline in Oilfield Services, while Fuel Specialties remained relatively stable.

Innospec Inc. announces its 2024 financial results, showcasing growth in Performance Chemicals and Fuel Specialties segments offsetting a decline in Oilfield Services.

Innospec Inc.'s 2023 annual report reveals a year of mixed performance, with growth in Oilfield Services offsetting declines in Performance Chemicals, alongside strategic acquisitions and a focus on long-term growth.

INNOSPEC Director Milton C. Blackmore filed an amended Form 4 to correct reported sale prices for common stock transactions on February 27, 2026.

Innospec Director Larry Padfield filed an amended Form 4 to correct reported sale prices for common stock transactions on February 27, 2026.

Innospec Inc. Director Claudia Poccia filed an amended Form 4 to correct the reported transaction prices for two sales of common stock on February 27, 2026.

Innospec Director David Landless filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.

INNOSPEC's EVP & CFO, Ian Cleminson, filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.

Innospec Inc. Director Milton C. Blackmore reported the sale of 594 shares of common stock at $76.5562 per share.

Innospec Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, emphasizing strong corporate governance and sustainability.

Innospec Inc. will hold its annual stockholder meeting on May 9, 2025, and has made proxy materials available online.

Innospec Inc. has released its proxy statement for the 2025 Annual Meeting of Stockholders, outlining key proposals, corporate governance practices, and executive compensation details.

Innospec Inc. will hold its annual stockholder meeting on May 10, 2024, to vote on the election of directors, executive compensation, and the ratification of the independent registered accounting firm.

Innospec Inc. releases its proxy statement outlining proposals for the 2024 Annual Meeting of Stockholders, including the election of directors and executive compensation.

Allspring Global Investments Holdings, LLC has increased its beneficial ownership of Innospec Inc. common stock to 7.7%, holding 1,892,471 shares.

Vanguard Capital Management reports beneficial ownership of 1,300,194 shares, representing 5.22% of Innospec Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 7.51% in Innospec Inc. common stock as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership in Innospec Inc. following an internal realignment that disaggregated reporting responsibilities.

Wasatch Advisors LP has filed an Amendment No. 3 to Schedule 13G, reporting a 2.1% passive beneficial ownership stake in Innospec Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 14.7% of Innospec Inc.'s common stock as of March 31, 2025.